Table IV.
Univariate analysis of mortality and morbidity for 2020 patients according to COVID-19 infection status
| Outcomes | No Infection (N = 5,318) | Asymptomatic (N = 513) | Symptomatic (N = 61) | P value (no infection versus asymptomatic) | P value (no infection versus symptomatic) |
|---|---|---|---|---|---|
| Mortality | 136 (2.6) | 25 (4.9) | 13 (21.3) | <.001 | <.001 |
| Overall morbidity | 1,459 (27.4) | 240 (46.8) | 49 (80.3) | <.001 | <.001 |
| Bleeding | 343 (6.4) | 44 (8.6) | 6 (9.8) | .08 | .42 |
| Surgical site infection | 744 (14.0) | 127 (24.8) | 19 (31.1) | <.001 | <.001 |
| Thromboembolic disease | 172 (3.2) | 28 (5.5) | 7 (11.5) | .01 | .001 |
| Pulmonary infection | 155 (2.9) | 62 (12.1) | 38 (62.3) | <.001 | <.001 |
| Pulmonary insufficiency | 305 (5.7) | 88 (17.2) | 24 (39.3) | <.001 | <.001 |
| Overall pulmonary complications | 395 (7.4) | 116 (22.6) | 40 (65.6) | <.001 | <.001 |
| Renal insufficiency | 327 (6.1) | 60 (11.7) | 13 (21.3) | <.001 | <.001 |
Data are reported as nb (%) unless otherwise specified.
COVID-19, coronavirus disease 2019.